NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE39857 Query DataSets for GSE39857
Status Public on Jun 20, 2015
Title The RALA pathway can maintain the proliferation of KRAS- and BRAF-mutated cancer cells
Organism Homo sapiens
Experiment type Expression profiling by array
Summary By silencing of RALA, a downstream member of the RAS signal transduction pathway, we aimed to determine whether genes downstream of a mutated KRAS (codon 12 or 13) or a mutated BRAF can have significant functions in colorectal cancer carcinogenesis.
 
Overall design RALA was silenced in three colorectal cancer cell lines (SW480, HCT116 and HT29). Effects were normalized to mock-transfected cells and the effects of scramble siRNA were excluded.
SW480, HCT116 and HT29 cell lines were treated with the PI3K inhibitor LY294002 or DMSO.
 
Contributor(s) Gyorffy B, Stelniec-Klotz I, Schäfer R
Citation(s) 26033452
Submission date Aug 02, 2012
Last update date Mar 25, 2019
Contact name Balazs Györffy
E-mail(s) zsalab2@yahoo.com
Organization name Hungarian Academy of Sciences
Street address Bókay 53
City Budapest
ZIP/Postal code H1083
Country Hungary
 
Platforms (2)
GPL96 [HG-U133A] Affymetrix Human Genome U133A Array
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Samples (15)
GSM980430 SW480 cells treated with transfection reagents only
GSM980431 SW480 cells treated with Scrambled siRNA (nonsense sequence)
GSM980432 SW480 cells treated with RALA-specific siRNA
Relations
BioProject PRJNA171925

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE39857_RAW.tar 63.0 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap